US Stock MarketDetailed Quotes

INSTITUTE BIOMEDICAL RESH CORP (MRES)

Watchlist
  • 0.0018
  • -0.0001-5.26%
15min DelayClose Apr 17 14:57 ET
4.87MMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INSTITUTE BIOMEDICAL RESH CORP (MRES) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2010
(Q2)Sep 30, 2010
(Q1)Jun 30, 2010
(FY)Mar 31, 2010
(Q4)Mar 31, 2010
(Q3)Dec 31, 2009
(Q2)Sep 30, 2009
(Q1)Jun 30, 2009
(FY)Mar 31, 2009
(Q4)Mar 31, 2009
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
94.71%-5.18K
-38.58%-23.02K
-24.48%-31.28K
43.00%-231.77K
34.45%-92.11K
-18.87%-97.92K
80.34%-16.61K
74.68%-25.13K
-313.83%-406.62K
-124.28%-140.52K
Net income from continuing operations
45.42%-55.69K
-263.10%-76.92K
-158,371.31%-50.08M
38.32%-273.4K
20.95%-118.58K
-11.50%-102.03K
77.71%-21.18K
70.39%-31.6K
91.74%-443.29K
5.88%-150.02K
Depreciation and amortization
126.93%12.93K
155.49%12.93K
1,020,660.25%51.67M
-19.41%22.58K
33.04%6.75K
-26.23%5.7K
-34.50%5.06K
-32.37%5.06K
148.29%28.01K
-43.86%5.08K
Other non cash items
--0
--0
---1.63M
-58.71%2.34K
----
----
----
----
-99.83%5.66K
----
Change In working capital
2,469.10%37.57K
8,425.41%40.96K
678.78%11.01K
457.30%16.72K
1,499.60%17.38K
-212.16%-1.59K
-117.40%-492
--1.41K
109.50%3K
-139.99%-1.24K
-Change in receivables
--0
----
----
----
----
--3.75K
----
----
----
----
-Change in prepaid assets
----
----
--0
----
----
----
----
--1.41K
----
----
-Change in payables and accrued expense
804.16%37.57K
1,653.47%40.96K
--11.01K
457.30%16.72K
557.30%19.72K
---5.34K
--2.34K
--0
112.00%3K
--3K
Cash from discontinued investing activities
Operating cash flow
94.71%-5.18K
-38.58%-23.02K
-24.48%-31.28K
43.00%-231.77K
34.45%-92.11K
-18.87%-97.92K
80.34%-16.61K
74.68%-25.13K
-313.83%-406.62K
-124.28%-140.52K
Investing cash flow
Cash flow from continuing investing activities
0
-223.92%-23.66K
-8.46K
0
93.19%-7.3K
0
Net PPE purchase and sale
----
----
----
-2.70%-7.5K
205.41%7.7K
----
----
----
93.19%-7.3K
75.57%-7.3K
Net other investing changes
----
----
----
---16.16K
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--0
-223.92%-23.66K
---8.46K
----
----
--0
93.19%-7.3K
--0
Financing cash flow
Cash flow from continuing financing activities
-95.42%5.18K
38.58%23.02K
24.48%31.28K
-38.29%255.43K
-28.43%100.57K
37.32%113.12K
-80.34%16.61K
-76.41%25.13K
101.40%413.92K
125.60%140.52K
Net issuance payments of debt
-95.42%5.18K
38.58%23.02K
24.48%31.28K
----
----
--113.12K
--16.61K
--25.13K
----
----
Net common stock issuance
----
----
----
----
----
----
----
----
59.19%17.31K
----
Net other financing activities
----
----
----
-35.60%255.43K
----
----
----
----
103.75%396.61K
122.25%123.22K
Cash from discontinued financing activities
Financing cash flow
-95.42%5.18K
38.58%23.02K
24.48%31.28K
-38.29%255.43K
-28.43%100.57K
37.32%113.12K
-80.34%16.61K
-76.41%25.13K
101.40%413.92K
125.60%140.52K
Net cash flow
Beginning cash position
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
End cash Position
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Free cash flow
95.42%-5.18K
-38.58%-23.02K
-24.48%-31.28K
42.19%-239.27K
39.93%-84.41K
-37.32%-113.12K
80.34%-16.61K
76.41%-25.13K
-101.40%-413.92K
-125.60%-140.52K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Dec 31, 2010(Q2)Sep 30, 2010(Q1)Jun 30, 2010(FY)Mar 31, 2010(Q4)Mar 31, 2010(Q3)Dec 31, 2009(Q2)Sep 30, 2009(Q1)Jun 30, 2009(FY)Mar 31, 2009(Q4)Mar 31, 2009
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 94.71%-5.18K-38.58%-23.02K-24.48%-31.28K43.00%-231.77K34.45%-92.11K-18.87%-97.92K80.34%-16.61K74.68%-25.13K-313.83%-406.62K-124.28%-140.52K
Net income from continuing operations 45.42%-55.69K-263.10%-76.92K-158,371.31%-50.08M38.32%-273.4K20.95%-118.58K-11.50%-102.03K77.71%-21.18K70.39%-31.6K91.74%-443.29K5.88%-150.02K
Depreciation and amortization 126.93%12.93K155.49%12.93K1,020,660.25%51.67M-19.41%22.58K33.04%6.75K-26.23%5.7K-34.50%5.06K-32.37%5.06K148.29%28.01K-43.86%5.08K
Other non cash items --0--0---1.63M-58.71%2.34K-----------------99.83%5.66K----
Change In working capital 2,469.10%37.57K8,425.41%40.96K678.78%11.01K457.30%16.72K1,499.60%17.38K-212.16%-1.59K-117.40%-492--1.41K109.50%3K-139.99%-1.24K
-Change in receivables --0------------------3.75K----------------
-Change in prepaid assets ----------0------------------1.41K--------
-Change in payables and accrued expense 804.16%37.57K1,653.47%40.96K--11.01K457.30%16.72K557.30%19.72K---5.34K--2.34K--0112.00%3K--3K
Cash from discontinued investing activities
Operating cash flow 94.71%-5.18K-38.58%-23.02K-24.48%-31.28K43.00%-231.77K34.45%-92.11K-18.87%-97.92K80.34%-16.61K74.68%-25.13K-313.83%-406.62K-124.28%-140.52K
Investing cash flow
Cash flow from continuing investing activities 0-223.92%-23.66K-8.46K093.19%-7.3K0
Net PPE purchase and sale -------------2.70%-7.5K205.41%7.7K------------93.19%-7.3K75.57%-7.3K
Net other investing changes ---------------16.16K------------------------
Cash from discontinued investing activities
Investing cash flow ----------0-223.92%-23.66K---8.46K----------093.19%-7.3K--0
Financing cash flow
Cash flow from continuing financing activities -95.42%5.18K38.58%23.02K24.48%31.28K-38.29%255.43K-28.43%100.57K37.32%113.12K-80.34%16.61K-76.41%25.13K101.40%413.92K125.60%140.52K
Net issuance payments of debt -95.42%5.18K38.58%23.02K24.48%31.28K----------113.12K--16.61K--25.13K--------
Net common stock issuance --------------------------------59.19%17.31K----
Net other financing activities -------------35.60%255.43K----------------103.75%396.61K122.25%123.22K
Cash from discontinued financing activities
Financing cash flow -95.42%5.18K38.58%23.02K24.48%31.28K-38.29%255.43K-28.43%100.57K37.32%113.12K-80.34%16.61K-76.41%25.13K101.40%413.92K125.60%140.52K
Net cash flow
Beginning cash position --0--0--0--0--0--0--0--0--0--0
End cash Position --0--0--0--0--0--0--0--0--0--0
Free cash flow 95.42%-5.18K-38.58%-23.02K-24.48%-31.28K42.19%-239.27K39.93%-84.41K-37.32%-113.12K80.34%-16.61K76.41%-25.13K-101.40%-413.92K-125.60%-140.52K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -